Search Stock News and Analysis

Gilead Sciences Stock Drops After Goldman Says "Sell"

https://www.schaeffersresearch.com/content/news/2019/05/28/gilead-sciences-stock-drops-after-goldman-says-sell

5/28/2019 9:27 AM

Goldman Sachs downgraded Gilead Sciences, Inc. (NASDAQ:GILD) to "sell" from "neutral," and slashed its price target by $10 to $60 -- a discount to last Friday's close at $66.89. The brokerage firm s...

Arthritis Drug Data Powers Galapagos, Gilead Sciences Stock Rallies

https://www.schaeffersresearch.com/content/news/2019/03/29/arthritis-drug-data-powers-galapagos-gilead-sciences-stock-rallies

3/29/2019 10:23 AM

Galapagos NV (NASDAQ:GLPG) and Gilead Sciences, Inc. (NASDAQ:GILD) stocks are higher this morning, after the companies reported positive data for a jointly developed drug to treat moderate-to-severe...

BMO Sets High Price Targets on 2 Drug Stocks

https://www.schaeffersresearch.com/content/news/2019/03/15/bmo-sets-high-price-targets-on-2-drug-stocks

3/15/2019 9:40 AM

Brokerage firm BMO just began coverage on Amgen, Inc. (NASDAQ:AMGN) and Gilead Sciences, Inc. (NASDAQ:GILD), expecting major upside from both stocks. Let's take a closer look at the bull notes, alon...

Gilead Sciences Set to Test Support After NASH Drug Failed

https://www.schaeffersresearch.com/content/news/2019/02/12/gilead-sciences-set-to-test-support-after-nash-drug-failed

2/12/2019 9:28 AM

The shares of Gilead Sciences, Inc. (NASDAQ:GILD) are down 3.1% in electronic trading, after the biotech said a late-stage trial for its Non-Alcoholic Steatohepatitis (NASH) drug, selonsertib, failed...

Dow Futures Higher Ahead of Disney Earnings, Trump Speech

https://www.schaeffersresearch.com/content/ezines/2019/02/05/dow-futures-higher-ahead-of-disney-earnings-trump-speech

2/5/2019 9:14 AM

U.S. stock futures are modestly higher this morning, though the Nasdaq-100 Index (NDX) is lagging its peers amid concerns about rising costs for Google parent Alphabet (GOOGL) after last night's q...

PEOPLE ALSO SEARCH FOR